Publication | Closed Access

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial

ThrombosisVenous DiseaseVenous ThrombosisOpen-label RandomizedHematologyPediatricsRevive TrialMedicineAnticoagulantVenous Thromboembolic EventsHeparins